UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004194
Receipt No. R000005040
Scientific Title A randomized phase III study of continuous maintenance Bevacizumab with or without Pemetrexed after induction therapy of Carboplatin, Pemetrexed, and Bevacizumab in patients with advanced non-squamous non-small-cell lung cancer whose EGFR mutation status is not active (other than Exon 19 deletion or Exon 21 point mutation) or is not known
Date of disclosure of the study information 2010/09/13
Last modified on 2019/08/20 16:47:41

No. Disposal Last modified on Item of update
1 Insert 2010/09/13 11:21:47
2 Update 2011/03/25 12:04:14


Key inclusion criteria
Key inclusion criteria
3 Update 2011/03/25 12:06:21 Address
Name of person sending information
Name of person sending information
Address1
4 Update 2011/06/21 10:32:23 Organization
Organization
Category of Funding Organization
5 Update 2012/02/14 12:55:44 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
6 Update 2012/02/14 18:37:02 Public title
Public title
Acronym
Acronym
7 Update 2012/04/10 09:10:17 Key inclusion criteria
8 Update 2013/03/29 14:08:26 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
9 Update 2014/09/17 09:47:56 Email
Name of person sending information
Name of person sending information
Post marketing survey by drug manufacture etc., specified by Japanese law.
10 Update 2015/09/14 16:50:30 Recruitment status
11 Update 2019/03/22 10:08:59 Recruitment status
Date of IRB
Last follow-up date
12 Update 2019/08/20 16:47:41 Recruitment status


Contact us.